subscribeSubscribe
Gland Pharma`s Generic Dihydroergotamine Mesylate Receives Approval in the U.S.

Gland Pharma`s Generic Dihydroergotamine Mesylate Receives Approval in the U.S.
FDA
18 Aug 2023
Share Share
Pulmatrix Announces Positive Top Line Results from a Phase 1 Study with PUR3100

Pulmatrix Announces Positive Top Line Results from a Phase 1 Study with PUR3100
PR NEWSWIRE
04 Jan 2023
Share Share
Satsuma peels off fresh strip of long-term migraine study data

Satsuma peels off fresh strip of long-term migraine study data
Nick Paul Taylor FIERCEPHARMA
26 Sep 2022
Share Share
Impel Pharma Announces Second Quarter 2022 Financial Results

Impel Pharma Announces Second Quarter 2022 Financial Results
GLOBENEWSWIRE
15 Aug 2022
Share Share
Impel NeuroPharma Provides Updates on Trudhesa Launch

Impel NeuroPharma Provides Updates on Trudhesa Launch
GLOBENEWSWIRE
18 Jan 2022
Share Share
Amneal`s Generic Dihydroergotamine Mesylate Receives Approval in the U.S.

Amneal`s Generic Dihydroergotamine Mesylate Receives Approval in the U.S.
FDA
04 Jan 2022
Share Share
Cyrano Appoints John Kollins to its Board of Directors

Cyrano Appoints John Kollins to its Board of Directors
PRNEWSWIRE
09 Nov 2021
Share Share
Satsuma Pharmaceuticals Announces the Appointment of Mutya Harsch BOD

Satsuma Pharmaceuticals Announces the Appointment of Mutya Harsch BOD
GLOBENEWSWIRE
12 Oct 2021
Share Share
Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray

Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray
GLOBENEWSWIRE
28 Sep 2021
Share Share
FDA Approvals Roundup: Trudhesa, Brukinsa, Keytruda

FDA Approvals Roundup: Trudhesa, Brukinsa, Keytruda
Renee Matthews RAPS
08 Sep 2021
Share Share